» Articles » PMID: 37982866

24-h Urine Collection in Patients with Urolithiasis: Perspective on Renal Function

Overview
Journal Urolithiasis
Publisher Springer
Specialty Urology
Date 2023 Nov 20
PMID 37982866
Authors
Affiliations
Soon will be listed here.
Abstract

A prospective observational study involving consecutive patients diagnosed with symptomatic urolithiasis was conducted to evaluate the serial change of urinary protein and 24-h urine chemistry with time after surgical procedures for urolithiasis. A consecutive 24-h urine samples, including calcium, uric acid and citrate were collected before surgical treatments, 4 ~ 8 weeks after surgery and 6 months after surgery. The urinary protein to creatinine ratio was also repeated at each timepoint. Forty-seven patients completed the study. The quantity of 24-h urine chemistry, including calcium, uric acid and citrate, changed over time and tended to increase (p = 0.013, 0.076 and 0.004, respectively), but the changes were not prominent during short-term follow-up. In contrast, the urinary protein to creatinine ratio decreased (p < 0.001) after surgical treatment for symptomatic renal stones, and the change was reflected in short-term follow-up. However, the serial changes in the urinary protein to creatinine ratio were significantly related to the serial changes in the 24-h urinary chemistry (p < 0.001). Surgical decompression for symptomatic urolithiasis could decrease the urinary protein to creatinine ratio, indicating improvement from renal damage, which may be reflected in the increase in 24-h urinary chemistry, including calcium, uric acid and citrate. These results strengthen the previous guidelines for the timing of 24-h urine collection and provide new insight into the optimal timing from the perspective of renal function.

Citing Articles

Machine Learning Models Decoding the Association Between Urinary Stone Diseases and Metabolic Urinary Profiles.

Ma L, Qiao Y, Wang R, Chen H, Liu G, Xiao H Metabolites. 2024; 14(12).

PMID: 39728455 PMC: 11678200. DOI: 10.3390/metabo14120674.


DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway.

Liu F, Bai Y, Wan Y, Luo S, Zhang L, Wu X Front Pharmacol. 2024; 15:1447241.

PMID: 39170709 PMC: 11336418. DOI: 10.3389/fphar.2024.1447241.

References
1.
Norman R, Bath S, Robertson W, Peacock M . When should patients with symptomatic urinary stone disease be evaluated metabolically?. J Urol. 1984; 132(6):1137-9. DOI: 10.1016/s0022-5347(17)50064-6. View

2.
Laube N, Pullmann M, Hergarten S, Schmidt M, Hesse A . The alteration of urine composition due to stone material present in the urinary tract. Eur Urol. 2003; 44(5):595-9. DOI: 10.1016/s0302-2838(03)00365-8. View

3.
Kadlec A, Greco K, Fridirici Z, Gerber D, Turk T . Effect of renal function on urinary mineral excretion and stone composition. Urology. 2011; 78(4):744-7. DOI: 10.1016/j.urology.2011.04.007. View

4.
Piao S, Park J, Son H, Jeong H, Cho S . Evaluation of renal function in patients with a main renal stone larger than 1 cm and perioperative renal functional change in minimally invasive renal stone surgery: a prospective, observational study. World J Urol. 2015; 34(5):725-32. DOI: 10.1007/s00345-015-1653-x. View

5.
Levey A, Stevens L, Coresh J . Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009; 53(3 Suppl 3):S4-16. DOI: 10.1053/j.ajkd.2008.07.048. View